PARI acquires Nortev, manufacturer of an equine respiratory therapy device

Article

Acquisition displays 2 companies combining their expertise in innovative veterinary inhalation devices

Flexineb E3 for Equine Inhalation Therapy (Photo courtesy of PARI Respiratory Equipment, Inc).

Flexineb E3 for Equine Inhalation Therapy (Photo courtesy of PARI Respiratory Equipment, Inc).

PARI Respiratory Equipment, Inc, manufacturer of medical devices and pharmaceuticals in the respiratory and inhalation industry, has acquired the Irish company Nortev, which manufactures and sells the equine nebulizer Flexineb, a device for respiratory therapy in horses by nebulizing medication or saline. Nortev also provides nebulization devices for companion animals.

Founded in 2008 in Galway, Ireland, Nortev distributes its products to over 30 countries in Europe, North America, Australia, and the Middle East.1 Its portfolio of customers features renowned veterinary clinics, horse studs, horse trainers, along with professional and leisure riders.

"Our goal is to establish PARI's more than 100 years of experience in inhalation therapy in the field of animal inhalation. With Nortev we have found a company that, like us at PARI, develops and sells innovative inhalation devices with the highest quality standards,” expressed Arne W. Dirks, PARI CEO, in a company release.1 “Together, we can develop new inhalation therapies that benefit horses and small animals with respiratory diseases – and thus also their owners."

Nortev will continue to be led by the 2 founders Gavan O'Sullivan and Declan Moran as an independent company. "I look forward to further developing our Flexineb equine nebulizer under the PARI umbrella," added Nortev CEO and managing director Gavan O'Sullivan, in the release. "There will be no changes for our Flexineb customers as a result of the acquisition. With PARI's support, we will enhance our core vision of continuous improvement and innovation in animal respiratory healthcare."1

This marks the first acquisition under PARI's growth and diversification strategy spearheaded by Dirks, through which PARI is getting access to a promising market. It also opens up synergy potential.

Reference

PARI acquires Nortev, the manufacturer of the equine inhaler Flexineb®. News release. PARI Respiratory Equipment, Inc. May 15, 2023. Accessed May 15, 2023. https://www.prnewswire.com/news-releases/pari-acquires-nortev-the-manufacturer-of-the-equine-inhaler-flexineb-301824553.html

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.